These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 24412596)

  • 61. Cutting edge: T cell requirement for CD28 costimulation is due to negative regulation of TCR signals by PTEN.
    Buckler JL; Walsh PT; Porrett PM; Choi Y; Turka LA
    J Immunol; 2006 Oct; 177(7):4262-6. PubMed ID: 16982858
    [TBL] [Abstract][Full Text] [Related]  

  • 62. IL-11 Induces Encephalitogenic Th17 Cells in Multiple Sclerosis and Experimental Autoimmune Encephalomyelitis.
    Zhang X; Kiapour N; Kapoor S; Khan T; Thamilarasan M; Tao Y; Cohen S; Miller R; Sobel RA; Markovic-Plese S
    J Immunol; 2019 Sep; 203(5):1142-1150. PubMed ID: 31341075
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Distinct Expression of Inflammatory Features in T Helper 17 Cells from Multiple Sclerosis Patients.
    Capone A; Bianco M; Ruocco G; De Bardi M; Battistini L; Ruggieri S; Gasperini C; Centonze D; Sette C; Volpe E
    Cells; 2019 Jun; 8(6):. PubMed ID: 31167379
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Myelin Basic Protein-Induced Production of Tumor Necrosis Factor-α and Interleukin-6, and Presentation of the Immunodominant Peptide MBP85-99 by B Cells from Patients with Relapsing-Remitting Multiple Sclerosis.
    Nielsen CH; Börnsen L; Sellebjerg F; Brimnes MK
    PLoS One; 2016; 11(1):e0146971. PubMed ID: 26756931
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Naive CD4 T-cell activation identifies MS patients having rapid transition to progressive MS.
    Zastepa E; Fitz-Gerald L; Hallett M; Antel J; Bar-Or A; Baranzini S; Lapierre Y; Haegert DG
    Neurology; 2014 Feb; 82(8):681-90. PubMed ID: 24453076
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Mechanism of neuroinflammation: enhanced cytotoxicity and IL-17 production via CD46 binding.
    Yao K; Graham J; Akahata Y; Oh U; Jacobson S
    J Neuroimmune Pharmacol; 2010 Sep; 5(3):469-78. PubMed ID: 20661655
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Altered Serum Cytokine Profiles in Relapse Phase of Relapsing-Remitting Multiple Sclerosis.
    Peiravian F; Rajaian H; Samiei A; Gholijani N; Gharesi-Fard B; Mokaram P; Rahimi-Jaberi A; Kamali Sarvestani E
    Iran J Immunol; 2016 Sep; 13(3):186-96. PubMed ID: 27671510
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Natural Killer Cells Regulate Th17 Cells After Autologous Hematopoietic Stem Cell Transplantation for Relapsing Remitting Multiple Sclerosis.
    Darlington PJ; Stopnicki B; Touil T; Doucet JS; Fawaz L; Roberts ME; Boivin MN; Arbour N; Freedman MS; Atkins HL; Bar-Or A
    Front Immunol; 2018; 9():834. PubMed ID: 29867923
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Phenotypic characteristics of aged CD4
    Suarez-Álvarez B; Rodríguez RM; Schlangen K; Raneros AB; Márquez-Kisinousky L; Fernández AF; Díaz-Corte C; Aransay AM; López-Larrea C
    Aging Cell; 2017 Apr; 16(2):293-303. PubMed ID: 28026094
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Endogenous interleukin-6 amplifies interleukin-17 production and corticoid-resistance in peripheral T cells from patients with multiple sclerosis.
    Ferreira TB; Hygino J; Barros PO; Teixeira B; Kasahara TM; Linhares UC; Lopes LM; Vasconcelos CC; Alvarenga R; Wing AC; Andrade RM; Andrade AF; Bento CA
    Immunology; 2014 Dec; 143(4):560-8. PubMed ID: 24919524
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Changes in Th17 cells function after nanocurcumin use to treat multiple sclerosis.
    Dolati S; Ahmadi M; Rikhtegar R; Babaloo Z; Ayromlou H; Aghebati-Maleki L; Nouri M; Yousefi M
    Int Immunopharmacol; 2018 Aug; 61():74-81. PubMed ID: 29852475
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Micro-RNA 18b and interleukin 17A profiles in relapsing remitting multiple sclerosis.
    Mohamed MS; Nahrery EMAE; Shalaby N; Hussein M; Aal RAE; Mohamed MM
    Mult Scler Relat Disord; 2019 Feb; 28():226-229. PubMed ID: 30623862
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Distinct Cytokine and Chemokine Expression in Plasma and Calpeptin-Treated PBMCs of a Relapsing-Remitting Multiple Sclerosis Patient: A Case Report.
    Chandran R; Capone M; Matzelle D; Polcyn R; Kau E; Haque A; Banik NL
    Neurochem Res; 2018 Dec; 43(12):2224-2231. PubMed ID: 30291537
    [TBL] [Abstract][Full Text] [Related]  

  • 74. NK/T cell ratios associate with interleukin-2 receptor alpha chain expression and shedding in multiple sclerosis.
    Mimpen M; Rolf L; Muris AH; Gerlach O; Poelmans G; Hupperts R; Smolders J; Damoiseaux J
    J Neuroimmunol; 2021 Apr; 353():577499. PubMed ID: 33529846
    [TBL] [Abstract][Full Text] [Related]  

  • 75. [Relapsing-remitting multiple sclerosis: clinical and immunological aspects of the pathology on the example Sema4D and CD72].
    Danchenko IY; Baidina TV; Kuklina EM; Trushnikova TN; Nekrasova IV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2019; 119(10. Vyp. 2):63-71. PubMed ID: 31934990
    [TBL] [Abstract][Full Text] [Related]  

  • 76. IL-17A is associated with the breakdown of the blood-brain barrier in relapsing-remitting multiple sclerosis.
    Setiadi AF; Abbas AR; Jeet S; Wong K; Bischof A; Peng I; Lee J; Bremer M; Eggers EL; DeVoss J; Staton T; Herman A; von Büdingen HC; Townsend MJ
    J Neuroimmunol; 2019 Jul; 332():147-154. PubMed ID: 31034962
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Endogenous CD28 expressed on myeloma cells up-regulates interleukin-8 production: implications for multiple myeloma progression.
    Shapiro VS; Mollenauer MN; Weiss A
    Blood; 2001 Jul; 98(1):187-93. PubMed ID: 11418479
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Redox Imbalance in CD4+ T Cells of Relapsing-Remitting Multiple Sclerosis Patients.
    Tavassolifar MJ; Moghadasi AN; Esmaeili B; Sadatpour O; Vodjgani M; Izad M
    Oxid Med Cell Longev; 2020; 2020():8860813. PubMed ID: 33354282
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Multiple sclerosis: T-cell resistance to regulation in RRMS linked to IL-6 pathway.
    Malpass K
    Nat Rev Neurol; 2013 Mar; 9(3):122. PubMed ID: 23419368
    [No Abstract]   [Full Text] [Related]  

  • 80. Fewer LAG-3
    Jones BE; Maerz MD; Bahnson HT; Somasundaram A; McCarthy LH; Speake C; Buckner JH
    J Immunol; 2022 Feb; 208(3):594-602. PubMed ID: 35022272
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.